These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 12529559

  • 1. The molecular perspective: VEGF and angiogenesis.
    Goodsell DS.
    Stem Cells; 2003; 21(1):118-9. PubMed ID: 12529559
    [No Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I.
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [Abstract] [Full Text] [Related]

  • 3. VEGF and the quest for tumour angiogenesis factors.
    Ferrara N.
    Nat Rev Cancer; 2002 Oct; 2(10):795-803. PubMed ID: 12360282
    [Abstract] [Full Text] [Related]

  • 4. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
    Breier G, Heidenreich R, Gaumann A, Groot M, Licht A, Nicolaus A, Schmitz J, Reichmann E, Plate KH, Vajkoczy P.
    Ann Hematol; 2002 Oct; 81 Suppl 2():S71-2. PubMed ID: 12611084
    [No Abstract] [Full Text] [Related]

  • 5. The biology of VEGF and its receptors.
    Ferrara N, Gerber HP, LeCouter J.
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [Abstract] [Full Text] [Related]

  • 6. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
    Zielke A, Middeke M, Hoffmann S, Colombo-Benkmann M, Barth P, Hassan I, Wunderlich A, Hofbauer LC, Duh QY.
    Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
    [Abstract] [Full Text] [Related]

  • 7. [Vascular endothelial growth factor receptor--structure and function].
    Liu L, Hu BC, Zhang YJ.
    Sheng Li Ke Xue Jin Zhan; 2000 Jul; 31(3):269-72. PubMed ID: 12545721
    [No Abstract] [Full Text] [Related]

  • 8. Neuroblastoma, apoptosis, and growth factors.
    Beierle EA, Dai W, Langham MR, Chen MK.
    Am Surg; 2003 Jan; 69(1):28-31. PubMed ID: 12575776
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor and its receptors in multiple myeloma.
    Ria R, Roccaro AM, Merchionne F, Vacca A, Dammacco F, Ribatti D.
    Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045
    [Abstract] [Full Text] [Related]

  • 10. [Vascular endothelial growth factor--fundamental research and experimental study in plastic surgery].
    Huang CY, Shen ZY.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jan; 16(1):64-9. PubMed ID: 11826659
    [Abstract] [Full Text] [Related]

  • 11. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 12. Angiogenesis in hematologic malignancies.
    Mesters RM.
    Ann Hematol; 2002 Jun; 81 Suppl 2():S72-4. PubMed ID: 12611085
    [No Abstract] [Full Text] [Related]

  • 13. VEGFs, angiopoietins, Ephrins and their receptors: putative targets for tumor therapy?
    Marmé D.
    Ann Hematol; 2002 Jun; 81 Suppl 2():S66. PubMed ID: 12611080
    [No Abstract] [Full Text] [Related]

  • 14. New vessel formation and aberrant VEGF/VEGFR signaling in acute leukemia: does it matter?
    de Bont ES, Neefjes VM, Rosati S, Vellenga E, Kamps WA.
    Leuk Lymphoma; 2002 Oct; 43(10):1901-9. PubMed ID: 12481883
    [Abstract] [Full Text] [Related]

  • 15. Double target for tumor mass destruction.
    Saharinen P, Alitalo K.
    J Clin Invest; 2003 May; 111(9):1277-80. PubMed ID: 12727916
    [No Abstract] [Full Text] [Related]

  • 16. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
    Kim MH.
    J Cell Biochem; 2003 Jun 01; 89(3):529-38. PubMed ID: 12761886
    [Abstract] [Full Text] [Related]

  • 17. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
    La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F, Capella C.
    Hum Pathol; 2003 Jan 01; 34(1):18-27. PubMed ID: 12605362
    [Abstract] [Full Text] [Related]

  • 18. VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels.
    Argraves WS, Larue AC, Fleming PA, Drake CJ.
    Dev Dyn; 2002 Nov 01; 225(3):298-304. PubMed ID: 12412012
    [Abstract] [Full Text] [Related]

  • 19. A targeted approach for antiangiogenic therapy of metastatic human colon cancer.
    Ellis LM.
    Am Surg; 2003 Jan 01; 69(1):3-10. PubMed ID: 12575772
    [Abstract] [Full Text] [Related]

  • 20. Molecular control of lymphangiogenesis.
    Baldwin ME, Stacker SA, Achen MG.
    Bioessays; 2002 Nov 01; 24(11):1030-40. PubMed ID: 12386934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.